| Authors: |
Gentile C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA 02215.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Feng WW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lenahan SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ying AW; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA 02215.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Card DC; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA 02215.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wu FTH; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Clinician Investigator Program, University of British Columbia, Vancouver, BC, Canada., Pham NA; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Radulovich N; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Cao PM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Hueniken K; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Li Q; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Tsao MS; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada., Kulesza J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hinkley MM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA 02215.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Liao L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Tsai JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Köhler J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Facchinetti F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Weston C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Locquet MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ngo K; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Gokhale PC; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Sacher AG; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Immunology, University of Toronto, ON, Canada., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA 02215.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA. |
